UNITED THERAPEUTICS Corp 4

Louis W. Sullivan, a non-employee director of United Therapeutics Corp, received an annual award of 2,380 stock options and corrected his reported indirect common stock holdings held by trust.

On July 22, 2026, United Therapeutics Corp non-employee director Louis W. Sullivan received an annual equity award of 2,380 stock options, with no explicit exercise price stated in the excerpt and a vesting schedule tied to the earlier of the one-year anniversary of the June 25, 2027 anticipated annual shareholder meeting or that meeting date itself, and an expiration date of July 22, 2033. The Form 4 also clarifies that his indirect holdings of common stock held via a trust had previously been understated by 590 shares, and confirms that these trust-held shares are in addition to 2,903 shares held directly as disclosed in an earlier July 13, 2026 filing. After this award and correction, Sullivan beneficially owns 2,983 shares of common stock directly and 1,457 shares indirectly through the trust, plus the newly awarded 2,380 options, all representing routine director compensation and an administrative correction rather than an open-market purchase or sale.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001193522-26-000002

Alert Tier

5